Healthcare DIVE October 12, 2023
Rebecca Pifer

The company announced a 2024 earnings outlook below Wall Street expectations on Thursday, two days after announcing a new chief executive officer.

Dive Brief:

  • Walgreens announced a 2024 earnings outlook below Wall Street expectations on Thursday, two days after announcing a new chief executive officer who the beleaguered retailer says will help with its strategic pivot to healthcare services.
  • Along with the release of its fourth quarter earnings, Walgreens said it expects adjusted earnings per share for its 2024 fiscal year to be between $3.20 to $3.50, below the analyst consensus of $3.71, due to lower profit from COVID-19 testing and vaccines among other factors.
  • On a call with investors Thursday morning, Walgreens leadership said the Deerfield, Illinois-based retailer...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Pharma, Pharma / Biotech, Primary care, Provider
Related Articles:
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations
Healthcare leaders urge Congress to recognize pharmacists as providers
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article